GDTC   $1.06  2.91% Market Closed After Close 1.0203 -3.75%

CytoMed Therapeutics Limited
Total Cash 6.82M
totalCashPerShare 0.591
EBITDA -3.12M
Total Debt 428.29K
quickRatio 19.199
currentRatio 21.534
Total Revenue 447.69K
debtToEquity 4.215
Revenue/Share 0.039
ROA -0.17438
ROE -0.26262
grossProfits
freeCashflow -2.59M
operatingCashflow -2.56M
earningsGrowth
revenueGrowth -0.211
grossMargins 1.00036
ebitdaMargins 0.0
operatingMargins -7.3597302
profitMargins 0.0
enterpriseValue 20.20M
forwardPE -15.366667
floatShares 3.55M
sharesOutstanding 11.54M
sharesShort 116.08K
sharesShortPriorMonth 122.65K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.69%
heldPercentInstitutions 0.00%
Short Ratio help_outline 10.61%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 0.881
Price To Book help_outline 2.62
earningsQuarterlyGrowth
netIncomeToCommon -3.06M
trailingEps -0.22%
forwardEps -0.15%
enterpriseToEbitda -6.47
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 1
lastUpdated Nov. 2, 2024, 6:13 a.m.